Top Markets
Coin of the day
Manzo Pharmaceuticals, Inc. Manzo Pharmaceuticals, Inc.

Manzo Pharmaceuticals, Inc.

MNZO
Rank in Stocks #40587
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the... Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.
Share Price
$0.0001
Last synced: 2026-08-12
Market Cap
$115.95K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Manzo Pharmaceuticals, Inc. (MNZO)

Category

Revenue for Manzo Pharmaceuticals, Inc. (MNZO)
Revenue in Aug 2026 TTM: 0
According to Manzo Pharmaceuticals, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Manzo Pharmaceuticals, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors